1,088
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore

A phase II, randomized, double-blind trial

, , , &
Pages 1308-1315 | Received 29 Nov 2012, Accepted 18 Feb 2013, Published online: 20 Feb 2013

References

  • Measles vaccines: WHO position paper. Wkly Epidemiol Rec 2009; 84:349 - 60; PMID: 19714924
  • Mumps virus vaccines. WHO position paper. Wkly Epidemiol Rec 2007; 82:49 - 60
  • Rubella vaccines: WHO position paper. Wkly Epidemiol Rec 2011; 86:301 - 16; PMID: 21766537
  • Varicella vaccines. WHO position paper. Wkly Epidemiol Rec 1998; 73:241 - 8; PMID: 9715106
  • Centers for Disease Control and Prevention (CDC). Progress in reducing measles mortality--worldwide, 1999-2003. MMWR Morb Mortal Wkly Rep 2005; 54:200 - 3; PMID: 15744229
  • Vesikari T, Sadzot-Delvaux C, Rentier B, Gershon A. Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine. Pediatr Infect Dis J 2007; 26:632 - 8; http://dx.doi.org/10.1097/INF.0b013e3180616c8f; PMID: 17596807
  • Czajka H, Schuster V, Zepp F, Esposito S, Douha M, Willems P. A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile. Vaccine 2009; 27:6504 - 11; http://dx.doi.org/10.1016/j.vaccine.2009.07.076; PMID: 19665608
  • Quian J, Rüttimann R, Romero C, Dall’Orso P, Cerisola A, Breuer T, et al. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997-2005. Arch Dis Child 2008; 93:845 - 50; http://dx.doi.org/10.1136/adc.2007.126243; PMID: 18456699
  • Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics 2011; 128:214 - 20; http://dx.doi.org/10.1542/peds.2010-3385; PMID: 21788222
  • Lin CC, Yang CY, Shih CT, Chen BH, Huang YL. Rubella seroepidemiology and catch-up immunization among pregnant women in Taiwan: comparison between women born in Taiwan and immigrants from six countries in Asia Am J Trop. Med Hyg (Geneve) 2010; 82:40 - 4; http://dx.doi.org/10.4269/ajtmh.2010.09-0302
  • Chang LY, Huang LM, Chang IS, Tsai FY. Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan. BMC Infect Dis 2011; 11:352; http://dx.doi.org/10.1186/1471-2334-11-352; PMID: 22176638
  • Huang WC, Huang LM, Chang IS, Tsai FY, Chang LY. Varicella breakthrough infection and vaccine effectiveness in Taiwan. Vaccine 2011; 29:2756 - 60; http://dx.doi.org/10.1016/j.vaccine.2011.01.092; PMID: 21315697
  • Chen JH, Tsou TP, Liu DP. Measles resurgence in Taiwan---lessons learned. J Formos Med Assoc 2009; 108:267 - 9; http://dx.doi.org/10.1016/S0929-6646(09)60065-6; PMID: 19369172
  • Cheng WY, Yang CF, Hou YT, Wang SC, Chang HL, Chiu HY, et al. Imported measles and implications for its elimination in Taiwan. Emerg Infect Dis 2011; 17:1523 - 6; PMID: 21801641
  • Jean-Jasmin LM, Lynette SP, Stefan M, Kai CS, Chew FT, Wah LB. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination. Southeast Asian J Trop Med Public Health 2004; 35:693 - 6; PMID: 15689089
  • Rentier B, Gershon AA, European Working Group on Varicella. Consensus: varicella vaccination of healthy children--a challenge for Europe. Pediatr Infect Dis J 2004; 23:379 - 89; http://dx.doi.org/10.1097/01.inf.0000122606.88429.8f; PMID: 15131459
  • Nolan T, McIntyre P, Roberton D, Descamps D. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine. Vaccine 2002; 21:281 - 9; http://dx.doi.org/10.1016/S0264-410X(02)00459-0; PMID: 12450703
  • Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, et al. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Pediatr Infect Dis J 2006; 25:12 - 8; http://dx.doi.org/10.1097/01.inf.0000195626.35239.58; PMID: 16395096
  • Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, et al. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J 2008; 27:724 - 30; http://dx.doi.org/10.1097/INF.0b013e318170bb22; PMID: 18600190
  • Rümke HC, Loch HP, Hoppenbrouwers K, Vandermeulen C, Malfroot A, Helm K, et al. Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses. Vaccine 2011; 29:3842 - 9; http://dx.doi.org/10.1016/j.vaccine.2011.02.067; PMID: 21382484
  • Goh P, Lim FS, Han HH, Willems P. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age. Infection 2007; 35:326 - 33; http://dx.doi.org/10.1007/s15010-007-6337-z; PMID: 17710370
  • Centers for disease control and prevention: Measles. In: Atkinson W, Hamborsky J, McIntyre L, Wolfe S (eds.): Epidemiology and prevention of vaccine-preventable diseases (9th edn). Public Health Foundation, Washington DC, 2006;125-44.
  • Jacobsen SJ, Ackerson BK, Sy LS, Tran TN, Jones TL, Yao JF, et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 2009; 27:4656 - 61; http://dx.doi.org/10.1016/j.vaccine.2009.05.056; PMID: 19520201
  • Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, et al, Vaccine Safety Datalink. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010; 126:e1 - 8; http://dx.doi.org/10.1542/peds.2010-0665; PMID: 20587679
  • Blatter MM, Klein NP, Shepard JS, Leonardi M, Shapiro S, Schear M, et al. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age. Pediatr Infect Dis J 2012; 31:e133 - 40; http://dx.doi.org/10.1097/INF.0b013e318259fc8a; PMID: 22622699
  • Committee on Infectious Diseases. Policy statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children. Pediatrics 2011; 128:630 - 2; http://dx.doi.org/10.1542/peds.2011-1968; PMID: 21873692
  • Berg AT, Shinnar S, Hauser WA, Alemany M, Shapiro ED, Salomon ME, et al. A prospective study of recurrent febrile seizures. N Engl J Med 1992; 327:1122 - 7; http://dx.doi.org/10.1056/NEJM199210153271603; PMID: 1528207
  • Chen SY, Tsai CN, Lai MW, Chen CY, Lin KL, Lin TY, et al. Norovirus infection as a cause of diarrhea-associated benign infantile seizures. Clin Infect Dis 2009; 48:849 - 55; http://dx.doi.org/10.1086/597256; PMID: 19239351